INTENSIVE CARE MEDICINE, vol.38, no.12, pp.1930-1945, 2012 (SCI-Expanded)
The recent increase in drug-resistant micro-organisms complicates the management of hospital-acquired bloodstream infections (HA-BSIs). We investigated the epidemiology of HA-BSI and evaluated the impact of drug resistance on outcomes of critically ill patients, controlling for patient characteristics and infection management.